Titre:
  • Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.
Auteur:van der Werff Ten Bosch, Jutte; Suciu, Stefan; Thyss, Antoine; Bertrand, Yves; Norton, Lucilia; Mazingue, F; Uyttebroeck, A; Lutz, Pierre; Robert, Alain; Boutard, Patrick; Ferster, Alina; Plouvier, Emmanuel; Maes, Peggy; Munzer, Martine; Plantaz, D; Dresse, Marie-Françoise; Philippet, Pierre; Sirvent, Nicolas; Waterkeyn, C; Vilmer, E; Philippe, N; Otten, Jacques
Informations sur la publication:Leukemia, 19, 5, page (721-726)
Statut de publication:Publié, 2005-05
Sujet CREF:Pédiatrie
Cancérologie
Hématologie
MeSH keywords:Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langue:Anglais
Identificateurs:urn:issn:0887-6924
info:doi/10.1038/sj.leu.2403689
info:pii/2403689
info:pmid/15744348